Concepedia

David Grainger

DG

Statistics

Publications

9

Citations

402

H-Index

9

Active since

1998

Affiliations

Eli Lilly (United States)(Current)

David Grainger is an author at Eli Lilly (United States) specializing in pharmacy, health policy, and medical technology assessment.

Publications per year

1998–2016

9

Publications

9

Coverage with Evidence Development: Applications and issues

Paul Trueman, David Grainger, K Downs · International Journal of Technology Assessment in Health Care · 2010 · 93 citations

Public Affairs, Health Policy, Pharmacoeconomics +16

A Pilot Study to Identify Areas for Further Improvements in Patient and Public Involvement in Health Technology Assessments for Medicines

Josie Messina, David Grainger · Patient · 2012 · 90 citations

Public Affairs, Health Policy, Health Services Research +16

Olanzapine vs risperidone in the management of schizophrenia: a randomized double-blind trial in Australia and New Zealand

Oye Gureje, Wayne Miles, Nicholas A Keks et al. · Schizophrenia Research · 2003 · 79 citations

Pharmacy, Pharmacotherapy, Psychiatry +13

RELATIONSHIP BETWEEN FINANCIAL IMPACT AND COVERAGE OF DRUGS IN AUSTRALIA

Josephine Mauskopf, Costel Chirila, Catherine Masaquel et al. · International Journal of Technology Assessment in Health Care · 2012 · 44 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacoeconomics +17

Annual health outcomes and treatment costs for schizophrenia populations.

Josephine Mauskopf, Kurt Anthony David, David Grainger et al. · PubMed · 1999 · 35 citations

Pharmacy, Pharmacoeconomics, Psychiatry +17

1–5 of 9